These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

869 related items for PubMed ID: 27177442

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Association of Dry Eye Symptoms and Signs in Patients with Dry Eye Disease.
    Tawfik A, Pistilli M, Maguire MG, Chen Y, Yu Y, Greiner JV, Asbell PA, Ying GS, Dry Eye Assessment and Management (DREAM) Study Research Group.
    Ophthalmic Epidemiol; 2024 Jun; 31(3):274-282. PubMed ID: 37592829
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of Dry Eye Disease in Children With Systemic Lupus Erythematosus and Healthy Controls.
    Ong Tone S, Elbaz U, Silverman E, Levy D, Williams S, Mireskandari K, Ali A.
    Cornea; 2019 May; 38(5):581-586. PubMed ID: 30933962
    [Abstract] [Full Text] [Related]

  • 6. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
    Messmer EM, von Lindenfels V, Garbe A, Kampik A.
    Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
    [Abstract] [Full Text] [Related]

  • 7. Correlation of Tear Film Osmolarity and 2 Different MMP-9 Tests With Common Dry Eye Tests in a Cohort of Non-Dry Eye Patients.
    Schargus M, Ivanova S, Kakkassery V, Dick HB, Joachim S.
    Cornea; 2015 Jul; 34(7):739-44. PubMed ID: 25909238
    [Abstract] [Full Text] [Related]

  • 8. Capability of the Inter-Eye Differences in Osmolarity, Break-Up Time and Corneal Staining on the Diagnostic of Dry Eye.
    Pena-Verdeal H, Garcia-Queiruga J, Sabucedo-Villamarin B, Giraldez MJ, García-Resúa C, Yebra-Pimentel E.
    Ocul Immunol Inflamm; 2024 Oct; 32(8):1674-1681. PubMed ID: 38051590
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. What is the value of incorporating tear osmolarity measurement in assessing patient response to therapy in dry eye disease?
    Amparo F, Jin Y, Hamrah P, Schaumberg DA, Dana R.
    Am J Ophthalmol; 2014 Jan; 157(1):69-77.e2. PubMed ID: 24060433
    [Abstract] [Full Text] [Related]

  • 13. Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study.
    Sheppard JD, Torkildsen GL, Lonsdale JD, D'Ambrosio FA, McLaurin EB, Eiferman RA, Kennedy KS, Semba CP, OPUS-1 Study Group.
    Ophthalmology; 2014 Feb; 121(2):475-83. PubMed ID: 24289915
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Automated Measurement of Tear Film Dynamics and Lipid Layer Thickness for Assessment of Non-Sjögren Dry Eye Syndrome With Meibomian Gland Dysfunction.
    Ji YW, Lee J, Lee H, Seo KY, Kim EK, Kim TI.
    Cornea; 2017 Feb; 36(2):176-182. PubMed ID: 28060064
    [Abstract] [Full Text] [Related]

  • 20. Effects of Prolonged Reading on Dry Eye.
    Karakus S, Agrawal D, Hindman HB, Henrich C, Ramulu PY, Akpek EK.
    Ophthalmology; 2018 Oct; 125(10):1500-1505. PubMed ID: 29705055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.